Before treatment, children with MIS-C had elevated serum concentrations of interleukin (IL)-10 (p=0.033), CRP (p=0.002) and IL-1 receptor antagonist (RA) (p=0.054) compared to children with other inflammatory conditions. The gene discussed is CRP; the disease is rheumatoid arthritis.